Stanford Impact Labs is currently accepting letters of interest for our second Impact Lab Start-Up Funding opportunity. Stanford Impact Labs makes 3-5 investments each cycle in start-up Impact Labs.
These pilot grants are intended to support the advancement of research into the impact of COVID-19 on the wellbeing, health service use, and health outcomes of populations that experience health disparities in the United States.
The Innovative Medicines Accelerator (IMA) aims to accelerate the prototyping of innovative medicines, and to enable hypothesis-driven studies on human subjects. This RFP seeks to leverage Stanford infrastructure to address the COVID-19 pandemic
The Innovative Medicines Accelerator (IMA) aims to accelerate the prototyping of innovative medicines, and to enable hypothesis-driven studies on human subjects. This RFP seeks to leverage Stanford infrastructure to address the COVID-19 pandemic
Stanford ChEM-H is soliciting seed grant proposals from postdoc teams for exploratory projects that align with the Institute’s mission to bridge chemistry or engineering with biomedical sciences or medicine.
Stanford AIM is seeking target-driven drug discovery proposals with compelling therapeutic rationale, identified protein target amenable to therapeutic intervention, and sufficient evidence for a drug discovery effort from PI-eligible faculty.
This grant is to attract and increase junior faculty members, including highly qualified physicians, physician-scientists, population-based or basic/translational scientists, and to maximize their potential to be leaders in academic medicine
Sustainability is the defining challenge of our time. Stanford aspires to Advance Climate Change Solutions and Foster a Healthy Planet & Healthy People through efforts to scale, partner, and educate. We seek projects to set this vision in motion.
